Nanosuspension -A Systemic Approaches In Drug Delivery System

Pharmacy

The enormous potential of nanometer-sized materials as a medication delivery system with a variety of applications is driving up interest in their manufacture and use. Because they are more affordable and technically straightforward than liposomes and other colloidal drug carriers, nanoscale systems have recently attracted a lot of attention as a means of resolving solubility difficulties. In comparison to other methods now on the market, nanosuspensions have shown to be more effective in increasing the bioavailability of a variety of medications with limited solubility. Parenteral, oral, pulmonary, and topical nanosuspensions have undergone substantial development for a variety of medications and have been tested for in vitro and in vivo applications. They have also been employed to target drug consumption. There are several preparation techniques for nanosuspensions that are being published and patented. In comparison to other nanotechnology-based applications, there are more products based on nanosuspension on the market and in clinical trials. Unexpectedly many novel drug candidates produced by drug discovery programmers are water insoluble and hence poorly bioavailable, which forces development attempts to be shelved. It is now possible to save these so-called "brickdust" candidates by converting them into crystalline nanosuspensions.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.